Jul 14, 2026

Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics:

·      Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00)

·      Case: A woman in her early 60s with multiregimen-recurrent...

Jul 11, 2026

Featuring an interview with Dr Jamie E Chaft, including the following topics:

• Case: A man in his early 70s with a 40 to 50 pack-year history of smoking and cT2bN1 squamous cell carcinoma of the lung with PD-L1 60% treated with induction therapy and surgery (00:00)
• Available clinical data with immunotherapy in the...

Jun 30, 2026

Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics:

• Introduction (0:00)
• Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09)
• Therapeutic Approaches Targeting ALK and ROS1 — Dr Langer (31:56)

CME information and select...

Jun 27, 2026

Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:

• Introduction (0:00)
• Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:38)
• Nonmetastatic EGFR-Mutated NSCLC, Exon 20 Insertion Mutations and Novel Agents — Dr...

Jun 18, 2026

Featuring a slide presentation and related discussion from Prof Martin Reck, including the following topics:

• Overview of small cell lung cancer (SCLC) (0:00)
• First-line chemoimmunotherapy for extensive-stage SCLC (ES-SCLC) (3:50)
• Lurbinectedin as first-line maintenance therapy for ES-SCLC (12:36)
• Case: A man in his...